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Abstract
The transcription profile of chipmunk parvovirus (ChpPV), a tentative member of the genus Erythrovirus in the subfamily
Parvovirinae of the family Parvoviridae, was characterized by transfecting a nearly full-length genome. We found that it is
unique from the profiles of human parvovirus B19 and simian parvovirus, the members in the genus Erythrovirus so far
characterized, in that the small RNA transcripts were not processed for encoding small non-structural proteins. However, like
the large non-structural protein NS1 of the human parvovirus B19, the ChpPV NS1 is a potent inducer of apoptosis. Further
phylogenetic analysis of ChpPV with other parvoviruses in the subfamily Parvovirinae indicates that ChpPV is distinct from
the members in genus Erythrovirus. Thus, we conclude that ChpPV may represent a new genus in the family Parvoviridae.
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Introduction
Parvoviruses, members of family Parvoviridae, are small, non-
enveloped icosahedral viruses. They contain a linear, single-
stranded DNA genome with terminal hairpin structures at both
ends. Parvoviruses that infect vertebrates and non-vertebrates are
classified as subfamilies Parvovirinae and Densovirinae, respectively.
There are five genera in the subfamily Parvovirinae: Parvovirus,
Dependovirus, Erythrovirus, Bocavirus and Amdovirus [1,2]. In addition
to human parvovirus B19 (B19V) and non-human primate
Erythrovirus [simian parvovirus (SPV) [3], pig-tailed macaque
parvovirus (PtMPV), and rhesus macaque parvovirus (RhMPV)
[4]], the genus Erythrovirus has two tentative members, the bovine
parvovirus type-3 (BPV3) [5] and the chipmunk parvovirus
(ChpPV) [6]. These two tentative members are classified as such
based mainly on their sequence similarities to other members.
ChpPV was initially isolated from Hepatitis B surface antigen
(HBsAg)-positive sera from Manchurian chipmunks in Korea, and
its genome is 47% identical to that of the prototype B19V [6]. The
putative capsid protein shows a homology of over 34% with those
of the B19V and SPV, but only less than 20% with those of other
parvoviruses [6]. Little is known about the molecular features of
this virus. The virus has not been isolated, and an infectious clone
has not been established.
The large non-structural protein (NS1) of parvoviruses is a
multifunctional viral nonstructural protein, which contains DNA
binding, ATPase, helicase and nuclease activity and is essential for
viral DNA replication [7]. The NS1 of parvoviruses in the genus
Erythrovirus and Parvovirus also has been shown to induce cell death,
which is critical to their pathogenesis [8–11]. However, the
Bocavirus NS1 per se does not induce cell death [12]. The B19V
NS1 induces apoptosis in both B19V permissive and non-
permissive cells [8,13,14]. The amino acid sequence of the
ChpPV NS1 diverges from that of the prototype B19V NS1 by
74.2% [6]. The potency of this novel parvovirus NS1 protein in
inducing apoptosis has not yet been examined.
In the current study, we have used a replication-competent
system in COS-7 cells to systematically characterize the transcrip-
tion profile of ChpPV. Finally, we evaluated the potency of the
novel ChpPV NS1 protein in inducing apoptosis in B19V semi-
permissive UT7/Epo-S1 cells [15].
Materials and Methods
Cells
COS-7 cells (CRL-1651; ATCC) were maintained in Dulbec-
co’s modified Eagle’s medium (DMEM) with 10% fetal calf serum
(FCS) at 37uCi n5 %C O 2. UT7/Epo-S1 cells were cultured in
DMEM with 10% FCS and 2 units/ml of Epo at 37uCi n5 %C O 2
as previously described [14,16].
Transfection
Two mg of DNA was transfected into COS-7 cells on one 60-
mm dish, using Lipofectamine and Plus reagents (Invitrogen) as
previously described [17]. UT7/Epo-S1 cells were transfected
with 2 mg of DNA per 2610
6 cells in a universal electroporation
reagent using the Nucleofector (Lonza, MD) as previously
described [17].
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(i) pC1ChpPV plasmid. A pCR II (Invitrogen) based
plasmid containing the genome of ChpPV without the left and
right ends was a gift from Dr. Byung Chui Yoo at Chung Ang
University Hospital, Korea. This pCRIIChipPV plasmid has an
extra sequence of 109 nts in front of the published ChipPV
sequence (Genbank accession no.: U86868). The whole ChpPV
sequence (nt 1–5,205) composed of a functional promoter region,
was deposited at Genbank as accession no. GQ200736. The
pC1ChpPV was constructed by replacing the B19V NSCap gene
with the ChpPV sequence of nt 1–5,205 in pC1NS1(2) [16,18].
(ii) GFP-fused NS1 construct. The NS1 ORFs of ChpPV
(nt 306–2438) and B19V (nt 616–2628, GenBank: AY386330.1)
were inserted into BamHI-XhoI digested pcDNAGFP_C3HA to
construct the pGFP-ChpPVNS1HA and pGFP-B19VNS1HA,
respectively. The pcDNAGFP_C3HA was constructed by
inserting a 3 6 HA-encoding sequence between XhoI and ApaI
sites in pcDNAGFP [16].
(iii) Clones used to generate probes for RNase protection
assays. To map the transcription units of ChpPV, we used
ChpPV P1, P2, P3, P4, P5, P6 and P7. These probes were
constructed by cloning the following regions of ChpPV into
BamHI-HindIII digested pGEM4Z (Promega): nt 110–318
(ChpPV P1), nt 2088–2488 (ChpPV P2), nt 2269–2588 (ChpPV
P3), nt 2669–2988 (ChpPV P4), nt 3092–3331 (ChpPV P5), nt
4909–5205 (ChpPV P6) and nt 1761–2000 (ChpPV P7).
RNA isolation and RNase protection
Total RNA was isolated from transfected cells 2 days
posttransfection using TRIZOL reagent (Invitrogen). Probes were
generated from BamHI-digested templates by in vitro transcription
with T7 polymerase using the MAXIscriptH kit (Ambion) and
following the manufacturer’s instructions. RNase protection assays
were performed essentially as previously described [19,20]. Signals
of RNase protection were quantified with the Storm 856 phosphor
imager and Image Quant TL software v2005 (GE Healthcare).
Relative molar ratios of individual RNA species were determined
after adjusting for the number of
32P-labeled uridines (U) in each
protected fragment as previously described [20].
Northern and Southern blotting analysis
Five mg of total RNA was used for Northern blotting analysis as
described previously [21,22]. Blots were hybridized with the
ChpPV NS, Cap and NSCap probes, which were amplified ChpPV
DNA fragments of nt 1–1561, nt 3281–5205 and nt 1–5205,
respectively, from the pC1ChpPV. Low-molecular-weight DNA
(Hirt DNA) was extracted from pC1ChpPV-transfected COS-7
cells, and DpnI digestion and Southern blotting were performed as
described previously [23] using the ChpPV NSCap probe. Signals
were developed by exposing the blots to X-ray films.
Western blotting analysis
SDS-PAGE and Western blotting were performed essentially as
described previously [23–25].
Flow cytometry analysis
Cells were double-stained live with Cy5-conjugated AnnexinV
(BD Biosciences) and Propidium Iodide (PI, Sigma) according to
the manufacturer’s instructions (BD Biosciences). All samples were
analyzed on the three-laser flow cytometer (LSR II, BD
Biosciences) at the Flow Cytometry Core of the University Kansas
Medical Center. Flow cytometry data were analyzed using FACS
DIVA software (BD Biosciences).
Results
The transcription profile of ChpPV is unique from those
of the members in the genus Erythrovirus
A nearly full-length genome of ChpPV was cloned into an
SV40-ori-containing plasmid. Replication of the ChpPV genome
on this plasmid in COS-7 cells was confirmed by Southern blotting
analysis, as the DpnI digestion-resistant DNA bands are shown
(Fig. 1, lane 4). Using this expression-capable ChpPV genome, we
obtained a detailed transcription profile of ChpPV, which was
generated following transfection of COS-7 cells.
RNase protection assays of ChpPV RNA
Total RNA isolated from pC1ChpPV transfected COS-7 cells
was subjected to RT-PCR with various primers based on the
transcription maps of B19V and SPV [26,27]. Transcription units
identified by RT-PCR were summarized in Fig. 2A, and were used
to design probes targeted to the promoter, intron donor and
acceptor sites, and polyadenylation sites, for use in RNase
protection assays.
ChpPV P1 probe
The ChpPV P1 probe, which spans the putative P3 promoter
(Fig. 2A), was protected to generate two bands of approximately
Figure 1. Replication of the construct pC1ChpPV in COS-7 cells.
COS-7 cells were transfected with pC1ChpPV. Hirt DNA sample was
extracted from the cells at 48 hrs post transfection, and were digested
with DpnI (DpnI +) vs. without DpnI (DpnI -). Samples were subjected to
Southern blotting analysis using the ChpPV NSCap probe (nt 1–5205).
Ten ng of pC1ChpPV plasmid DNA were treated in parallel as a DpnI-
digestion control (lane 2).
doi:10.1371/journal.pone.0015113.g001
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represent RNAs that were transcribed from the P3 promoter and
were unspliced and spliced at the first donor site (D1), respectively.
Thus, the P3 RNA initiation site was located at approximately nt
160, and the D1 site was confirmed to be at nt 300. The ChpPV
RNA spliced from the D1 site accumulated to approximately five
times greater levels than the ChpPV RNA that was unspliced at
the D1 (Fig. 2B, lane 1).
ChpPV P2 and P3 probes
The ChpPV P2 probe, which spans the putative A1-2 acceptor,
was protected to generate two bands of 401 nts and 354 nts
(Fig. 2B, lane 2). The bands at 401-nt and 354-nt represent RNAs
unspliced and spliced at the A1-2, respectively. The ChpPV P3
probe, which spans the putative D2 donor, protected two bands of
320 nts and 250 nts (Fig. 2B, lane 3). The bands at 320-nt and 250-
nt represent RNAs that were unspliced and spliced at the D2
donor, respectively. The ratio of RNA spliced vs. unspliced at the
D2 donor site was approximately 1:1.
ChpPV P4 and P5 probes
The ChpPV P4 probe, which spans the putative internal
polyadenylation site, was protected to yield bands at 303 nts and
approximately 180 nts (Fig. 2B, lane 4). The 303-nt and ,180-nt
bands represent RNAs read through and polyadenylated at the
(pA)p site, respectively. Apparently, less than half of the RNAs
were polyadenylated at the (pA)p site for RNAs that were
unspliced at the second intron. The ChpPV P5 probe, which
spans the A2 acceptor site of the second intron, protected bands of
240 nts and 139 nts (Fig. 2B, lane 5), which represent unspliced
and spliced RNAs at the A2 site, respectively. The ratio of RNA
spliced vs. unspliced at the A2 site was approximately 1:1.
ChpPV P6 and P7 probes
The ChpPV P6 probe, which spans the distal polyadenylation
site [(pA)d], was protected to yield predominantly a single band of
approximately 210 nts (Fig. 2B, lane 6), enabling us to identify nt
5127 as the cleavage site at the (pA)d. The ChpPV P7 probe,
which spans the putative A1-1 acceptor, was protected to generate
bands of 240 nts and 153 nts (Fig. 2B, lane 8), which represent
RNAs that are unspliced and spliced at the A1-1 site, respectively.
The ratio of RNA that was spliced vs. unspliced RNA at the A1-1
site was approximately 1:5. Alternative acceptor usage of the first
intron of ChpPV, which we have confirmed in this study, was
similar to that of B19V and SPV [26,27]. However, splicing of
ChpPV RNA at the A1-1 created a potential long 7.5kDa-like
ORF, i.e., NS2 ORF (Fig. 3B).
Northern blotting analysis of ChpPV RNA
Northern blotting analysis of ChpPV RNAs presented a unique
profile that differed from that of other members of the genus
Erythrovirus in that no small RNAs were processed. Hybridization
of ChpPV RNA isolated from pC1ChpPV-transfected COS-7 cells
with the full NSCap probe revealed six abundant RNA species that
accumulated as bands of approximately 5.0 kb, 4.2 kb, 3.4 kb,
3.1 kb, 2.7 kb and 2.4 kb (Fig. 3A, lane 4). These six bands were
Figure 2. Transcription mapping of ChpPV RNA by RNase protection assays. (A) Schematic diagram of the ChpPV genome and the
probes used for analysis by RNase protection assays. The transcription units, with the promoter (P3), splice donor (D1 and D2) and acceptor (A1-1,
A1-2, A2) sites, and polyadenylation signals, (pA)p at nt 2841 and (pA)d at nt 5107, are indicated. All the ChpPV probes are shown with their
respective nucleotide numbers, along with the designated bands they are expected to protect and their predicted sizes. Spl, spliced RNAs; Unspl,
unspliced RNAs; RT, RNAs read-through the (pA)p site. (B) Mapping of the ChpPV transcription units by RNase protection assays. Ten mg of total
RNA isolated two days after the transfection of COS-7 cells with plasmid pC1ChpPV were protected by ChpPV probes P1-P7. Lanes 7&9,
32P-labeled
RNA markers with sizes indicated.
doi:10.1371/journal.pone.0015113.g002
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NS probe (Fig. 3A, lane 2), indicating that all these species of
ChpPV RNA were generated from a single promoter located
upstream of the ChpPV genome. When using the Cap probe, we
detected all species of ChpPV RNA except for the 2.7 kb RNA
(Fig. 3A, lane 3). This suggested that the 2.7 kb RNA was
polyadenylated at an internal site. Unlike in the B19V and SPV
transcript profiles [26,27], we did not detect RNA bands smaller
than 2.4 kb with the three probes (Fig. 3A). This finding, together
with results obtained from both RNase protection and RT-PCR
analyses, suggests that a second acceptor site for the second intron
in the capsid proteins-encoding region is not present, precluding
the processing of small mRNAs that could encode an 11kDa-like
small non-structural protein as in the B19V and SPV transcription
maps [26,27].
A transcription map of ChpPV expression in COS-7 cells was
generated and is shown in Fig. 3B. Although the (pA)p site that lies
in the intron between the D2 donor and the A2 acceptor was
functional as assessed by RNase protection (Fig. 2B, lane 4), RNAs
that were spliced at the first intron (D1 to A1-1 or A1-2) were not
polyadenylated at the (pA)p. Only unspliced RNA was polyade-
nylated at the (pA)p and this was recognized as the R1 mRNA at
2.7 kb by both the NS and NSCap probes, but not by the Cap
probe, in Northern blots (Fig. 3A). The R5 mRNA that was spliced
from D1 to A1-1 sites and polyadenylated at the (pA)d likely
encodes a small non-structural protein (NS2).
Phylogenetic relationship of ChpPV with other
parvoviruses in the subfamily Parvovirinae
Since the transcription map of the ChpPV is different from
those of the B19V [18,26] and SPV [27,28] in the genus
Erythrovirus, which show an abundance of small RNAs produced
through alternative splicing and polyadenylation [26,27], we
reexamined the phylogenetic relationship of ChpPV with other
parvoviruses in the subfamily Parvovirinae. The new ChpPV
sequence GQ200736 that has 109 nts extended from the left
hand of the genome [6], and the nucleotide sequences of 17
members in the subfamily Parvovirinae were compared. BioEdit
Version 7 (http://www.mbio.ncsu.edu/bioedit/bioedit.html) was
used for sequence analysis [29]. The sequences were aligned using
ClustalW (implanted in BioEdit Version 7). The phylogenetic tree
was then determined by the Neighbor-Joining/UPGMA method
version 3.6a2.1 (implanted in BioEdit Version 7), with the distance
between nucleotide sequences indicated by the length of the
branch. In addition, amino acid sequences of the ChpPV NS1 and
VP1 proteins were aligned with those of the other 17 members in
the subfamily Parvovirinae. As shown in Fig. 4, the ChpPV genome,
NS1 and VP1 protein sequences are still distinct from those of the
members in the genus Erythrovirus, though the genome and VP1
protein are relatively closer than other genera. The NS1 protein is
relatively closer to that of the adeno-associated viruses (AAV)
(Fig. 4B). Taken together, these results support that ChpPV does
not belong to the genus Erythrovirus.
Figure 3. Transcription profile of ChpPV RNA. (A) Northern blotting analysis. Total RNA was isolated from COS-7 cells transfected with
pC1ChpPV, and was used for Northern blotting analysis. The blots were hybridized to three ChpPV DNA probes (NSCap, NS1 and Cap) that spanned
various regions of the ChpPV genome, as diagramed at the bottom of panel B. Sizes of the RNA bands detected by each probe are indicated in kb to
the right side of each lane. The RNA marker ladder is shown in lane 1. (B) Transcription map of ChpPV. The ChpPV genome is shown to scale, with
transcription landmarks indicated. All of the RNA species detected in our assays are diagrammed to display their identities and respective sizes in the
absence of the polyA tail. The putative ORFs that each can encode are also diagramed, and the predicted sizes (kDa) of translated proteins are
indicated to the right.
doi:10.1371/journal.pone.0015113.g003
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in UT7/Epo-S1 cells
Because of the lack of the small RNAs to encode an 11kDa-like
protein in the ChpPV transcription profile, we examined the
proapoptotic nature of the ChpPV NS1. We transfected GFP-
fused ChpPV NS1 construct into UT7/Epo-S1 cells. GFP-fused
B19V NS1 and GFP alone were used as positive and negative
controls, respectively. Transfected cells were confirmed to express
the full length GFP-fused ChpPV and B19V NS1 at 24 hrs post
transfection (Fig. 5A, lanes 3&4). Transfected cells were co-stained
alive with AnnexinV and PI, followed by flow cytometry analysis.
At 24 hrs post transfection, results showed that the ChpPV NS1
protein behaved much like B19V NS1, inducing a significantly
higher percentage of AnnexinV+ cells in the GFP-ChpPVNS1-
expressing population (GFP+) compared with the GFP control
(Fig. 5B, 24 hrs). In the GFP+ population, transfection of GFP-
ChpPVNS1 and GFP-B19VNS1 induced an AnnexinV+/PI-
population of 11.5% and 20.5%, respectively, which represent
cells at early stages of apoptosis, and induced an AnnexinV+/PI+
population of 9.4% and 4.4%, respectively, which represent cells
at late stages of apoptosis. At 48 and 72 hrs post transfection, the
percentages of AnnexinV+/PI+ population in GFP-ChpPVNS1-
and GFP-B19VNS1-trasnfected cells (GFP+) were consistently
increased as a consequence of progressing apoptosis, which are
significantly higher than those of the GFP control (Fig. 5B,
48&72 hrs). We observed an overall ,15% of AnnexinV+
population in the GFP control group at 48 and 72 hrs post
transfection, which, presumably, was induced by the electropora-
tion and the GFP. Taken together, these results suggest that,
similar to the B19V NS1, the novel ChpPV NS1 protein is also an
apoptosis inducer.
Discussion
We have characterized the detailed transcription profile of
ChpPV by transfecting a nearly-full length clone in COS-7 cells,
which shows unique features from those of the members of the
genus Erythrovirus. All ChpPV RNAs were generated from a single
pre-mRNA that was transcribed from only one promoter, which
was located at the beginning of the left-hand of the genome.
ChpPV pre-mRNA contains two introns and two polyadenylation
sites, and in this respect is similar to the pre-mRNA of B19V and
SPV [18,26–28]. However, unlike members in the genus
Erythrovirus, ChpPV did not generate small RNA transcripts
following transfection of COS-7 cells, suggesting that a small
protein, i.e., 11 kDa in B19V, is not expressed during virus
infection. Moreover, in all the four viruses in the genus Erythrovirus,
including B19V, SPV, PtMPV and RhMPV, an 11kDa-like ORF
is present and overlaps with the C-terminus of the VP1/2 ORF
[30]. The amino acid sequence alignment of the 11kDa-like
proteins among the four members shows a great similarity at the
C-terminus, indicating that the 11kDa-like protein is likely an
essential and conserved non-structural protein in the genus
Erythrovirus. However, no ORF longer than 25 amino acids is
present in a different frame at the C-terminus of the ChpPV VP1/
2 ORF [30].
The transcription profiles of B19V and SPV characterized by
transfection of their genomes in COS-7 cells were similar to those
identified during virus infection of permissive cells [18,27,31,32].
We believe that the ChpPV transcription profile characterized in
COS-7 cells reflects the profile expressed during virus infection.
Therefore, the unique transcription profile of ChpPV that we have
characterized distinguishes the virus from the members in the
genus Erythrovirus.
B19V infection induces cell death through an apoptotic
pathway, in both primary erythroid cells and B19V semi-
permissive cell lines, and this cell death has been attributed to
the NS1 protein [8,13]. However, we have recently discovered
that the small non-structural protein 11 kDa, which is expressed
abundantly, induces apoptosis during B19V infection [14]. In
contrast, small RNAs that encode an 11kDa-like protein were not
generated by transfecting the ChpPV genome into COS-7 cells
(Fig. 3A). Nevertheless, our results have confirmed that the
divergent ChpPV NS1 protein possesses a similar potency in
inducing apoptosis in B19V-permissive cells, indicating that the
ChpPV NS1 protein may play a key role in viral pathogenesis as
Figure 4. Phylogenetic analysis of ChpPV with the other 17 representative parvoviruses in each genus of Parvovirinae. Genome
sequences (A), NS1 (B) and VP1 (C) amino acid sequences of representative members in each genus of the subfamily Parvovirinae were used to
determine the neighbor-joining phylogenetic tree using BioEdit Version 7. Genbank accession numbers of the sequences used follow the name of the
virus.
doi:10.1371/journal.pone.0015113.g004
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several parvoviruses in the genera Erythrovirus, Parvovirus and
Dependovirus induces cytotoxicity (apoptosis) of infected cells [8–
11]. In addition, our characterization of the ChpPV transcription
profile suggests that a small non-structural protein (NS2) could be
expressed from a different reading frame that lies within the NS1-
encoding sequence, similar to the way in which B19V produces
the 7.5 kDa protein [33], Bocavirus minute virus of canines (MVC)
expresses the NP1 protein [23], and Parvovirus minute virus of mice
(MVM) produces the C-terminus of the NS2 protein [34].
Although the International Committee on Taxonomy of Viruses
(ICTV) has tentatively classified ChpPV as a species in the genus
Erythrovirus [1], our phylogenetic analysis of ChpPV with other
parvoviruses in the subfamily Parvovirinae indicates that ChpPV
does not belong to any present genus in Parvovirinae. Together with
the unique expression strategy of ChpPV that combines features
from the genera Parvovirus, Bocavirus and Erythrovirus, this finding
leads us to conclude that ChpPV may represent a new genus in the
subfamily Parvovirinae.
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